文献速递免疫规划

展示fHbp的纳米颗粒相比低价数fHbp抗原诱导更强的抗B群脑膜炎球菌分离株抗体反应

Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens.
PubMed 文献 · Vaccine · 2025-02-20

本研究在小鼠中比较了表面展示脑膜炎球菌H因子结合蛋白(fHbp)的纳米颗粒(fHbp-NP)与低价数fHbp抗原的免疫原性。fHbp-NP免疫小鼠对同源和异源fHbp变体的结合抗体滴度更高,且血清杀菌抗体活性显著高于低价数抗原或MenB-FHbp免疫组。结果表明纳米颗粒展示fHbp可诱导强效且广谱的抗体反应。

要点

  • fHbp-NP免疫小鼠对同源和异源fHbp变体的结合抗体滴度高于低价数fHbp抗原组。
  • fHbp-NP免疫小鼠血清对多种MenB分离株的杀菌抗体活性显著高于低价数抗原或MenB-FHbp组。
  • 纳米颗粒展示fHbp可诱导强效且广谱的抗体反应。

核心结论

  • 纳米颗粒展示fHbp可诱导强效且广谱的抗体反应。

研究设计与样本

  • 小鼠免疫研究,比较fHbp-NP与低价数fHbp抗原及MenB-FHbp的免疫原性。

主要发现

  • fHbp-NP免疫小鼠对同源和异源fHbp变体的结合抗体滴度高于低价数fHbp抗原免疫小鼠。
  • fHbp-NP免疫小鼠血清对多种MenB分离株的血清杀菌抗体活性显著高于低价数抗原或MenB-FHbp免疫小鼠。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Serogroup B meningococcus (MenB) is one of the leading causes of invasive meningococcal disease (IMD) in Western countries. While outbreaks of IMD are rare, this disease can lead to long-term disabilities and even death. These outbreaks typically occur in infants, children, and young adults. There are currently two licensed MenB vaccines: 4CMenB (Bexsero®; GSK Vaccines, Srl, Italy) and MenB-FHbp (Trumenba®, bivalent rLP2086; Pfizer Inc., Collegeville, PA). The effectiveness of these vaccines is dependent upon their ability to elicit a protective antibody response against the various disease-causing strains that are currently circulating. Real-world data has demonstrated that MenB vaccination is effective at preventing IMD. However, it has also been shown that the number of isolates covered by vaccination is limited and can vary from year to year as well as by geographical location. This suggests that a new MenB vaccine which elicits greater breadth of protection would be beneficial. Here we describe the generation of a nanoparticle (NP) displaying a meningococcal factor H-binding protein (fHbp) on its surface. Mice immunized with this fHbp-NP had higher binding antibody titers to both homologous and heterologous fHbp variants compared to mice immunized with low valency fHbp antigens. Importantly, sera from fHbp-NP immunized mice had significantly higher serum bactericidal antibody activity against a range of MenB isolates than mice immunized with low valency antigens or MenB-FHbp. Overall, these studies demonstrate that display of fHbp on nanoparticles elicits a potent and broad antibody response.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. McKechnie JL, Kepl E, Louth J, et al. Nanoparticles displaying fHbp elicit an enhanced antibody response against meningococcal B isolates compared to low valency fHbp antigens. Vaccine. 2025. PMID: 39983538. doi:10.1016/j.vaccine.2025.126885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。